0001213900-20-015051.txt : 20200615 0001213900-20-015051.hdr.sgml : 20200615 20200615173448 ACCESSION NUMBER: 0001213900-20-015051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200615 FILED AS OF DATE: 20200615 DATE AS OF CHANGE: 20200615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHARMA PANNA CENTRAL INDEX KEY: 0001157989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39318 FILM NUMBER: 20964353 MAIL ADDRESS: STREET 1: 201 ROUTE 17 NORTH CITY: RUTHERFORD STATE: NJ ZIP: 07070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lantern Pharma Inc. CENTRAL INDEX KEY: 0001763950 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463973463 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1920 MCKINNEY AVENUE STREET 2: 7TH FLOOR CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 972-277-1136 MAIL ADDRESS: STREET 1: 1920 MCKINNEY AVENUE STREET 2: 7TH FLOOR CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: Lantern Pharma DATE OF NAME CHANGE: 20190108 4 1 ownership.xml X0306 4 2020-06-15 0 0001763950 Lantern Pharma Inc. LTRN 0001157989 SHARMA PANNA C/O LANTERN PHARMA INC. 1920 MCKINNEY AVENUE, 7TH FLOOR DALLAS TX 75201 1 1 0 0 CEO & President Stock Option 15.00 2020-06-15 4 A 0 76628 A Common Stock 76628 76628 D Pursuant to an amendment to the Reporting Person's employment agreement, the Reporting Person was granted stock options to purchase 76,628 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering ("IPO") at an exercise price per share equal to the price per share sold in the Issuer's IPO. One third of the options will vest 180 days after the closing of the Issuer's IPO (the "Grant Date"), with the remaining two thirds of the options vesting in equal monthly increments over a thirty (30) month period commencing the 181st day after the Grant Date. All other terms and conditions of the option grant will be consistent with the terms and conditions permitted under the Issuer's Amended and Restated 2018 Equity Incentive Plan. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the Grant Date. /s/ Panna Sharma 2020-06-15